Healthcare / Medical Care FacilitiesHelsinki
$10.68
-0.18 (-1.66%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $59.1M · quality 61.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
34/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$240M
P/E
6.9x
↓EV/EBITDA
4.7x
↓ROE
19.7%
↑Gross Margin
70.9%
↑Debt/Equity
1.58
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-1.9%
FCF CAGR
+18.1%
FCF margin
9.1%
FCF / Net income
1.57x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $652.3M · net income $37.6M · FCF $59.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $652.3M | $652.3M | $704.4M | $720.0M | $690.5M |
| Net Income | $37.6M | $37.6M | $27.4M | $5.7M | $9.5M |
| EBITDA | $109.8M | $109.8M | $101.0M | $71.0M | $53.9M |
| EPS | 1.67 | 1.67 | 1.22 | 0.19 | 0.42 |
| Gross Margin | 70.9% | 70.9% | 71.6% | 64.6% | 61.3% |
| Operating Margin | 6.4% | 6.4% | 6.5% | 2.2% | 1.2% |
| Net Margin | 5.8% | 5.8% | 3.9% | 0.8% | 1.4% |
| Balance Sheet | |||||
| Debt/Equity | 1.58 | 1.58 | 1.92 | 1.58 | 3.23 |
| Current Ratio | 0.54 | 0.54 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $59.1M | $59.1M | $89.8M | $56.1M | $35.8M |
| Returns | |||||
| ROE | 19.7% | 19.7% | 16.0% | 3.9% | 7.7% |
| Valuation | |||||
| P/E | 6.89 | 6.89 | 9.09 | 37.47 | 20.95 |
| EV/EBITDA | 4.66 | 4.66 | 5.40 | 5.21 | 10.87 |
| P/B | 1.26 | 1.26 | 1.46 | 1.08 | 1.60 |
| Growth & Yield | |||||
| Revenue Growth | -7.4% | -7.4% | -2.2% | 4.3% | — |
| EPS Growth | 37.4% | 37.4% | 539.6% | -54.8% | — |
| Dividend Yield | 4.9% | 4.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-17.2%
EPS terminal req.
$0.95
Spread vs growth
54.6%
5Y implied EPS CAGR
-7.2%
EPS terminal req.
$1.15
Spread vs growth
44.6%
10Y implied EPS CAGR
1.0%
EPS terminal req.
$1.85
Spread vs growth
36.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-23.9%
Start / end P/E
12.3x → 6.4x
EPS bridge
1.22 → 1.67
Residual
-18.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.